The high KRT6A concentration was reported in the analysis of non-small-cell lung cancer (NSCLC) and lung adenocarcinoma (LADC) and is associated with lymph node metastasis and advanced T stage cancer [13,24,25]. This evidence concerns the gene KRT6A and metastatic malignant neoplasm in the lymph nodes.